{'_data': [['Unknown',
            [['GI',
              u'Musculoskeletal and connective tissue disorders Uncommon: Muscle cramp Nervous system disorders Common: Dizziness, headache Respiratory, thoracic and mediastinal disorders Common: Cough Skin and subcutaneous tissue disorders Uncommon: Rash Rare: Angioedema The following adverse reactions have been observed associated with ACE inhibitors therapy: Blood and lymphatic system disorders In a few patients agranulocytosis and pancytopenia may occur. There are reports of haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency. Metabolism and nutrition disorders Very rare hypoglycaemia Psychiatric disorders Rarely, depression, mood altered, sleep disorders, confusional state. Nervous system disorders Occasionally paraesthesia, dysgeusia, balance disorder. Eye disorders Rarely, vision blurred. Ear and labyrinth disorders Rarely, tinnitus. Cardiac disorders Individual cases of tachycardia, palpitations, arrhythmias, angina pectoris, myocardial infarction have been reported for ACE inhibitors in association with hypotension. Vascular Disorders Severe hypotension has occurred after initiation or increase of therapy. This occurs especially in certain risk groups (see Special warnings and precautions for use). In association with hypotension, symptoms like dizziness, feeling of weakness, impaired vision, rarely with disturbance of consciousness (syncope). Rarely flushing occurs. Respiratory, thoracic and mediastinal disorders Rarely dyspnoea, sinusitis, rhinitis, glossitis, bronchitis and bronchospasm have been reported. ACE inhibitors have been associated with the onset of angioneurotic oedema in a small subset of patients involving the face and oropharyngeal tissues. In isolated cases angioneurotic oedema involving the upper airways has caused fatal airway obstruction. Gastro-intestinal disorders Occasionally, abdominal pain, diarrhoea, constipation and dry mouth can occur. Individual cases of pancreatitis and ileus have been described in association with ACE inhibitors. Very rare small bowel angioedema Hepatobiliary disorders Individual cases of cholestatic jaundice and hepatitis have been described in association with ACE inhibitors. Skin, and appendages Occasionally allergic and hypersensitivity reactions can occur like pruritus, urticaria, erythema multiforme, Stevens-Johnson syndrome, toxic epidermic necrolysis, psoriasis-like efflorescences, alopecia. This can be accompanied by fever, myalgia, arthralgia, eosinophilia and/or increased ANA titers. Rarely hyperhidrosis occurs. Musculoskeletal and connective tissue disorders. Occasionally, myalgia can occur. Renal and urinary disorders Renal insufficiency may occur or be intensified. Acute renal failure has been reported (see Special warnings and precautions for use). Rarely micturition disorders occur. Reproductive system and breast disorders Rarely, erectile dysfunction.']]]],
 '_pages': [11, 13],
 u'_rank': 1,
 u'_type': u'LSFU'}